Hussain Fatma, Hafeez Javaria, Khalifa Amany S, Naeem Muhammad, Ali Tayyab, Eed Emad M
Clinico-Molecular Biochemistry Laboratory, Department of Biochemistry, University of Agriculture Faisalabad 38000, Pakistan.
Department of Clinical Pathology and Pharmaceutics, College of Pharmacy, Taif University P.O. Box 11099, Taif 21944, Saudi Arabia.
Am J Transl Res. 2022 Jun 15;14(6):3824-3839. eCollection 2022.
Diabetes mellitus is a multifactorial chronic disease that affects the human population and it is the third most common cause of death worldwide. is used as popular folk medicine and its action against diabetes mellitus remains unclear. We investigated the inhibitory potentials of α-glucosidase, acetylcholinesterase, and biochemical profiling of in alloxan-induced diabetic rat models.
An study was carried out by using twenty male albino Wistar rats randomly divided into five groups each comprising four rats. Diabetes mellitus was induced by single intraperitoneal administration of 80 mg/kg body weight of alloxan and treatment with plant extract was conducted for a period of thirty days to check their impact on body weight and differentblood values. Biochemical profiling and characterization were performed by assays and HPLC, and FTIR. Histopathologic effects of were examined through automated image analysis. Results were analyzed through Tukey's test, a complete randomized design and two factorial designs under CRD.
Methanolic extract demonstrated potent alpha-glucosidase (72.30 ± 1.17%) and acetylcholinesterase (50.12 ± 0.82%) inhibitory activities. HPLC analysis confirmed the existence of vital flavonoids, antioxidants, and saponins. FTIR revealed the presence of hydroxyl groups, esters, alkanes, alkenes, alkynes, ketones, alcohols, amines and carboxylic acids as major functional groups. Results of study demonstrated that co-administration of alloxan and methanolic extract of significantly improved the levels of fasting blood glucose, glycated hemoglobin and insulin in diabetic rats.
can be recommended as a therapeutic adjunct for diabetic patients as it can provide favorable remedial action in the context of the diabetes continuum of metabolic syndrome.
糖尿病是一种影响人类的多因素慢性疾病,是全球第三大常见死因。它被用作流行的民间药物,但其对糖尿病的作用仍不清楚。我们在四氧嘧啶诱导的糖尿病大鼠模型中研究了其对α-葡萄糖苷酶、乙酰胆碱酯酶的抑制潜力以及生化特征。
采用20只雄性白化Wistar大鼠进行研究,随机分为5组,每组4只。通过腹腔注射80mg/kg体重的四氧嘧啶诱导糖尿病,并对植物提取物进行为期30天的治疗,以检查其对体重和不同血液值的影响。通过酶法分析、高效液相色谱法和傅里叶变换红外光谱法进行生化特征分析和表征。通过自动图像分析检查其组织病理学效应。结果通过Tukey检验、完全随机设计和完全随机设计下的双因素设计进行分析。
甲醇提取物表现出强大的α-葡萄糖苷酶(72.30±1.17%)和乙酰胆碱酯酶(50.12±0.82%)抑制活性。高效液相色谱分析证实了重要黄酮类化合物、抗氧化剂和皂苷的存在。傅里叶变换红外光谱显示羟基、酯、烷烃、烯烃、炔烃、酮、醇、胺和羧酸作为主要官能团的存在。研究结果表明,四氧嘧啶与甲醇提取物联合给药显著改善了糖尿病大鼠的空腹血糖、糖化血红蛋白和胰岛素水平。
可推荐作为糖尿病患者的治疗辅助药物,因为它可以在代谢综合征糖尿病连续体的背景下提供有利的治疗作用。